<DOC>
	<DOCNO>NCT01560234</DOCNO>
	<brief_summary>This study investigate safety , tolerability , pharmacokinetics pharmacodynamics single ascend dos AZD8848 healthy subject .</brief_summary>
	<brief_title>AZD8848 Single Ascending Dose Study</brief_title>
	<detailed_description>A Double-blind , Placebo-controlled , Randomised Study Investigate Safety , Tolerability , Pharmacokinetics Pharmacodynamics Single Ascending Inhaled Doses AZD8848 Healthy Subjects</detailed_description>
	<criteria>Healthy men woman age 18 45 year ( inclusive ) suitable vein cannulation repeat venipuncture . Women childbearing potential must stable highly effective contraceptive method least 3 month prior Visit 1 ( screen ) willing continue choose contraceptive method Male subject willing use condom ( spermicide ) prevent pregnancy drug exposure female partner refrain donate sperm father child day investigational product administration 3 month Have body mass index ( BMI ) 18 30 kg/m2 weigh least 50 kg 100 kg Ability produce sputum good enough quality assessment biomarkers Abnormal vital sign , 10 minute supine rest , define follow ( SBP &gt; 140 mmHg , Diastolic blood pressure ( DBP ) &gt; 90 mmHg , Heart rate &lt; 40 &gt; 85 beat per minute ) Prolonged QTcF &gt; 450 m shorten QTcF &lt; 340 m family history long QT syndrome History severe allergy/hypersensitivity ongoing allergy/hypersensitivity , judge Investigator history hypersensitivity drug similar chemical structure class AZD8848 History additional risk factor Torsade de pointes ( e.g. , heart failure , hypokalaemia , family history Long QT syndrome , sudden death ) History asthma allergic rhinitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>healthy</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>pharmacodynamic</keyword>
	<keyword>inhale</keyword>
</DOC>